GLP1RAs¶
ID:
glp1ras-smwu-smiSource: smwu/SMI_GLP
Dataset: CPRD Gold
License: MIT
Date Created: 2025-07-30
Date Imported: 2026-05-07
Date Updated: 2026-05-07
Metadata¶
Downloads¶
Codelist preview¶
| prodcode | therapyevents | productname | ingredient | strength | formulation | route | bnftext | GLP-1RA |
|---|---|---|---|---|---|---|---|---|
| 89568 | 106 | Semaglutide 1.7mg/0.75ml solution for injection 3ml pre-filled disposable devices | Semaglutide | 2.27mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Semaglutide |
| 90172 | 1734 | Tirzepatide 5mg/0.6ml solution for injection 2.4ml pre-filled disposable devices | Tirzepatide | 8.333mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics)/Dual GIP And GLP-1 Receptor Agonists | Tirzepatide |
| 46469 | 23260 | Bydureon 2mg powder and solvent for prolonged-release suspension for injection vials (AstraZeneca UK Ltd) | Exenatide | 2mg | Powder and solvent for prolonged-release suspension for inj | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Exenatide |
| 69548 | 3507 | Saxenda 6mg/ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) | Liraglutide | 6mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Liraglutide |
| 63785 | 18682 | Dulaglutide 0.75mg/0.5ml solution for injection pre-filled disposable devices | Dulaglutide | 1.5mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Dulaglutide |
| 90626 | 0 | Ozempic 1mg/0.74ml solution for injection 3ml pre-filled pens (Pharmaram Ltd) | Semaglutide | 1.34mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Semaglutide |
| 62661 | 30396 | Bydureon 2mg powder and solvent for prolonged-release suspension for injection pre-filled pens (AstraZeneca UK Ltd) | Exenatide | 2mg | Powder and solvent for prolonged-release suspension for inj | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Exenatide |
| 35149 | 125400 | Exenatide 10micrograms/0.04ml solution for injection 2.4ml pre-filled disposable devices | Exenatide | 250microgram/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Exenatide |
| 55459 | 2259 | Lixisenatide 10micrograms/0.2ml solution for injection 3ml pre-filled disposable devices | Lixisenatide | 50microgram/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Lixisenatide |
| 75740 | 7486 | Ozempic 0.25mg/0.19ml solution for injection 1.5ml pre-filled pens (Novo Nordisk Ltd) | Semaglutide | 1.34mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Semaglutide |
| 75397 | 11292 | Semaglutide 0.25mg/0.19ml solution for injection 1.5ml pre-filled disposable devices | Semaglutide | 1.34mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Semaglutide |
| 35144 | 9730 | Byetta 5micrograms/0.02ml solution for injection 1.2ml pre-filled pens (AstraZeneca UK Ltd) | Exenatide | 250microgram/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Exenatide |
| 80987 | 1159 | Exenatide 2mg/0.85ml prolonged-release suspension for injection pre-filled disposable devices | Exenatide | 2.353mg/1ml | Prolonged-release suspension for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Exenatide |
| 90199 | 444 | Tirzepatide 7.5mg/0.6ml solution for injection 2.4ml pre-filled disposable devices | Tirzepatide | 12.5mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics)/Dual GIP And GLP-1 Receptor Agonists | Tirzepatide |
| 82709 | 31385 | Semaglutide 7mg tablets | Semaglutide | 7mg | Oral tablet | Oral | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Semaglutide |
| 89358 | 957 | Wegovy FlexTouch 1mg/0.75ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) | Semaglutide | 1.34mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Semaglutide |
| 90048 | 9593 | Mounjaro KwikPen 2.5mg/0.6ml solution for injection 2.4ml pre-filled pens (Eli Lilly and Company Ltd) | Tirzepatide | 4.167mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics)/Dual GIP And GLP-1 Receptor Agonists | Tirzepatide |
| 83130 | 13953 | Dulaglutide 3mg/0.5ml solution for injection pre-filled disposable devices | Dulaglutide | 6mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Dulaglutide |
| 76021 | 38911 | Ozempic 1mg/0.74ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) | Semaglutide | 1.34mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Semaglutide |
| 35251 | 21194 | Exenatide 5micrograms/0.02ml solution for injection 1.2ml pre-filled disposable devices | Exenatide | 250microgram/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Exenatide |
| 83847 | 8766 | Trulicity 4.5mg/0.5ml solution for injection pre-filled pens (Eli Lilly and Company Ltd) | Dulaglutide | 9mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Dulaglutide |
| 89608 | 44 | Semaglutide 2.4mg/0.75ml solution for injection 3ml pre-filled disposable devices | Semaglutide | 3.2mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Semaglutide |
| 90536 | 734 | Mounjaro KwikPen 12.5mg/0.6ml solution for injection 2.4ml pre-filled pens (Eli Lilly and Company Ltd) | Tirzepatide | 20.833mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics)/Dual GIP And GLP-1 Receptor Agonists | Tirzepatide |
| 83875 | 1 | Insulin glargine 100units/ml / Lixisenatide 33micrograms/ml solution for injection 3ml pre-filled disposable devices | Lixisenatide | 33microgram/1ml + 100unit/1ml | Solution for injection | Subcutaneous | Intermediate- And Long-Acting Insulins/GLP-1 Receptor Agonists Plus Insulin | Lixisenatide |
| 62899 | 49190 | Xultophy 100units/ml / 3.6mg/ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) | Liraglutide | 100unit/1ml + 3.6mg/1ml | Solution for injection | Subcutaneous | Intermediate- And Long-Acting Insulins/GLP-1 Receptor Agonists Plus Insulin | Liraglutide |
| 55729 | 12903 | Lyxumia 20micrograms/0.2ml solution for injection 3ml pre-filled pens (Sanofi) | Lixisenatide | 100microgram/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Lixisenatide |
| 63336 | 151841 | Trulicity 1.5mg/0.5ml solution for injection pre-filled pens (Eli Lilly and Company Ltd) | Dulaglutide | 3mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Dulaglutide |
| 75938 | 27620 | Ozempic 0.5mg/0.37ml solution for injection 1.5ml pre-filled pens (Novo Nordisk Ltd) | Semaglutide | 1.34mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Semaglutide |
| 46458 | 8624 | Exenatide 2mg powder and solvent for prolonged-release suspension for injection vials | Exenatide | 2mg | Powder and solvent for prolonged-release suspension for inj | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Exenatide |
| 89476 | 838 | Wegovy FlexTouch 2.4mg/0.75ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) | Semaglutide | 3.2mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Semaglutide |
| 55723 | 812 | Lixisenatide 10micrograms/0.2ml solution for injection 3ml pre-filled disposable devices and Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices | Lixisenatide | NA | Not applicable | Route of administration not applicable | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Lixisenatide |
| 91455 | 0 | Rybelsus 7mg tablets (Pharmaram Ltd) | Semaglutide | 7mg | Oral tablet | Oral | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Semaglutide |
| 89369 | 696 | Wegovy FlexTouch 0.5mg/0.37ml solution for injection 1.5ml pre-filled pens (Novo Nordisk Ltd) | Semaglutide | 1.34mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Semaglutide |
| 89231 | 20 | Tirzepatide 2.5mg/0.5ml solution for injection pre-filled disposable devices | Tirzepatide | 5mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics)/Dual GIP And GLP-1 Receptor Agonists | Tirzepatide |
| 90254 | 4065 | Mounjaro KwikPen 7.5mg/0.6ml solution for injection 2.4ml pre-filled pens (Eli Lilly and Company Ltd) | Tirzepatide | 12.5mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics)/Dual GIP And GLP-1 Receptor Agonists | Tirzepatide |
| 85945 | 0 | Bydureon 2mg powder and solvent for prolonged-release suspension for injection pre-filled pens (CST Pharma Ltd) | Exenatide | 2mg | Powder and solvent for prolonged-release suspension for inj | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Exenatide |
| 63562 | 810 | Insulin degludec 100units/ml / Liraglutide 3.6mg/ml solution for injection 3ml pre-filled disposable devices | Liraglutide | 100unit/1ml + 3.6mg/1ml | Solution for injection | Subcutaneous | Intermediate- And Long-Acting Insulins/GLP-1 Receptor Agonists Plus Insulin | Liraglutide |
| 89876 | 300 | Mounjaro 2.5mg/0.5ml solution for injection pre-filled pens (Eli Lilly and Company Ltd) | Tirzepatide | 5mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics)/Dual GIP And GLP-1 Receptor Agonists | Tirzepatide |
| 82258 | 8546 | Rybelsus 3mg tablets (Novo Nordisk Ltd) | Semaglutide | 3mg | Oral tablet | Oral | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Semaglutide |
| 64622 | 0 | Bydureon 2mg powder and solvent for prolonged-release suspension for injection vials (Lexon (UK) Ltd) | Exenatide | 2mg | Powder and solvent for prolonged-release suspension for inj | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Exenatide |
| 90129 | 10686 | Mounjaro KwikPen 5mg/0.6ml solution for injection 2.4ml pre-filled pens (Eli Lilly and Company Ltd) | Tirzepatide | 8.333mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics)/Dual GIP And GLP-1 Receptor Agonists | Tirzepatide |
| 81073 | 0 | Victoza 6mg/ml solution for injection 3ml pre-filled pens (Mawdsley-Brooks & Company Ltd) | Liraglutide | 6mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Liraglutide |
| 89322 | 1529 | Wegovy FlexTouch 0.25mg/0.37ml solution for injection 1.5ml pre-filled pens (Novo Nordisk Ltd) | Semaglutide | 676microgram/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Semaglutide |
| 63823 | 78793 | Dulaglutide 1.5mg/0.5ml solution for injection pre-filled disposable devices | Dulaglutide | 3mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Dulaglutide |
| 80810 | 7527 | Bydureon BCise 2mg/0.85ml prolonged-release suspension for injection pre-filled pens (AstraZeneca UK Ltd) | Exenatide | 2.353mg/1ml | Prolonged-release suspension for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Exenatide |
| 90667 | 54 | Tirzepatide 12.5mg/0.6ml solution for injection 2.4ml pre-filled disposable devices | Tirzepatide | 20.833mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics)/Dual GIP And GLP-1 Receptor Agonists | Tirzepatide |
| 91411 | 3 | Diavic 6mg/ml solution for injection 3ml pre-filled pens (Sun Pharma UK Ltd) | Liraglutide | 6mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Liraglutide |
| 90200 | 188 | Tirzepatide 10mg/0.6ml solution for injection 2.4ml pre-filled disposable devices | Tirzepatide | 16.667mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics)/Dual GIP And GLP-1 Receptor Agonists | Tirzepatide |
| 83632 | 7228 | Dulaglutide 4.5mg/0.5ml solution for injection pre-filled disposable devices | Dulaglutide | 9mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Dulaglutide |
| 40693 | 380997 | Liraglutide 6mg/ml solution for injection 3ml pre-filled disposable devices | Liraglutide | 6mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Liraglutide |
| 90367 | 682 | Mounjaro KwikPen 15mg/0.6ml solution for injection 2.4ml pre-filled pens (Eli Lilly and Company Ltd) | Tirzepatide | 25mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics)/Dual GIP And GLP-1 Receptor Agonists | Tirzepatide |
| 90126 | 959 | Tirzepatide 2.5mg/0.6ml solution for injection 2.4ml pre-filled disposable devices | Tirzepatide | 4.167mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics)/Dual GIP And GLP-1 Receptor Agonists | Tirzepatide |
| 88761 | 126 | Mounjaro 5mg/0.5ml solution for injection pre-filled pens (Eli Lilly and Company Ltd) | Tirzepatide | 10mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics)/Dual GIP And GLP-1 Receptor Agonists | Tirzepatide |
| 55767 | 730 | Lyxumia 10micrograms/20micrograms treatment initiation pack (Sanofi) | Lixisenatide | NA | Not applicable | Route of administration not applicable | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Lixisenatide |
| 82909 | 21752 | Semaglutide 14mg tablets | Semaglutide | 14mg | Oral tablet | Oral | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Semaglutide |
| 35150 | 46781 | Byetta 10micrograms/0.04ml solution for injection 2.4ml pre-filled pens (AstraZeneca UK Ltd) | Exenatide | 250microgram/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Exenatide |
| 76624 | 70254 | Semaglutide 1mg/0.74ml solution for injection 3ml pre-filled disposable devices | Semaglutide | 1.34mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Semaglutide |
| 69947 | 4 | Albiglutide 30mg powder and solvent for solution for injection pre-filled disposable devices | Albiglutide | 30mg | Powder and solvent for solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Albiglutide |
| 83706 | 12715 | Rybelsus 14mg tablets (Novo Nordisk Ltd) | Semaglutide | 14mg | Oral tablet | Oral | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Semaglutide |
| 40642 | 183491 | Victoza 6mg/ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) | Liraglutide | 6mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Liraglutide |
| 62904 | 8905 | Exenatide 2mg powder and solvent for prolonged-release suspension for injection pre-filled disposable devices | Exenatide | 2mg | Powder and solvent for prolonged-release suspension for inj | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Exenatide |
| 89378 | 714 | Wegovy FlexTouch 1.7mg/0.75ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) | Semaglutide | 2.27mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Semaglutide |
| 55413 | 21214 | Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices | Lixisenatide | 100microgram/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Lixisenatide |
| 90668 | 60 | Tirzepatide 15mg/0.6ml solution for injection 2.4ml pre-filled disposable devices | Tirzepatide | 25mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics)/Dual GIP And GLP-1 Receptor Agonists | Tirzepatide |
| 89481 | 123 | Semaglutide 1mg/0.75ml solution for injection 3ml pre-filled disposable devices | Semaglutide | 1.34mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Semaglutide |
| 55728 | 772 | Lyxumia 10micrograms/0.2ml solution for injection 3ml pre-filled pens (Sanofi) | Lixisenatide | 50microgram/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Lixisenatide |
| 89962 | 15 | Tirzepatide 5mg/0.5ml solution for injection pre-filled disposable devices | Tirzepatide | 10mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics)/Dual GIP And GLP-1 Receptor Agonists | Tirzepatide |
| 83262 | 24386 | Trulicity 3mg/0.5ml solution for injection pre-filled pens (Eli Lilly and Company Ltd) | Dulaglutide | 6mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Dulaglutide |
| 76776 | 13 | Suliqua 100units/ml / 33micrograms/ml solution for injection 3ml pre-filled SoloStar pens (Sanofi) | Lixisenatide | 33microgram/1ml + 100unit/1ml | Solution for injection | Subcutaneous | Intermediate- And Long-Acting Insulins/GLP-1 Receptor Agonists Plus Insulin | Lixisenatide |
| 89317 | 507 | Semaglutide 0.25mg/0.37ml solution for injection 1.5ml pre-filled disposable devices | Semaglutide | 676microgram/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Semaglutide |
| 82697 | 17306 | Rybelsus 7mg tablets (Novo Nordisk Ltd) | Semaglutide | 7mg | Oral tablet | Oral | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Semaglutide |
| 82174 | 17405 | Semaglutide 3mg tablets | Semaglutide | 3mg | Oral tablet | Oral | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Semaglutide |
| 76777 | 31 | Suliqua 100units/ml / 50micrograms/ml solution for injection 3ml pre-filled SoloStar pens (Sanofi) | Lixisenatide | 100unit/1ml + 50microgram/1ml | Solution for injection | Subcutaneous | Intermediate- And Long-Acting Insulins/GLP-1 Receptor Agonists Plus Insulin | Lixisenatide |
| 63401 | 38366 | Trulicity 0.75mg/0.5ml solution for injection pre-filled pens (Eli Lilly and Company Ltd) | Dulaglutide | 1.5mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Dulaglutide |
| 75987 | 38429 | Semaglutide 0.5mg/0.37ml solution for injection 1.5ml pre-filled disposable devices | Semaglutide | 1.34mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics) | Semaglutide |
| 90187 | 2841 | Mounjaro KwikPen 10mg/0.6ml solution for injection 2.4ml pre-filled pens (Eli Lilly and Company Ltd) | Tirzepatide | 16.667mg/1ml | Solution for injection | Subcutaneous | Glucagon-Like Peptide-1 Receptor Agonists ( GLP-1 Receptor Agonists, Incretin Mimetics)/Dual GIP And GLP-1 Receptor Agonists | Tirzepatide |